Export

ATC codes: L01XA01
EMLc
Indication
Osteosarcoma of bone and articular cartilage of unspecified sites ICD11 code: 2C21.Z
INN
Cisplatin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 50 mg per 50 mL ; 100 mg per 100 mL
EML status history
First added in 1984 (TRS 722)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Cisplatin was originally added to the EML in 1984 and the EMLc in 2007. In 2009, cisplatin was replaced by carboplatin with a square box for treatment of advanced ovarian cancer. In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, cisplatin was added to the complementary list of the EML and EMLc for use in treatment protocols for osteosarcoma. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for osteosarcoma is attached.